Filtros de búsqueda

Lista de obras de Rebecca Coll

30

A small-molecule inhibitor of the NLRP3 inflammasome for the treatment of inflammatory diseases.

artículo científico publicado en 2015

Activation of the NLRP3 inflammasome by islet amyloid polypeptide provides a mechanism for enhanced IL-1β in type 2 diabetes

artículo científico publicado en 2010

Author Correction: Mitochondrial DNA synthesis fuels NLRP3 inflammasome

scholarly article by Rebecca Coll published in December 2018

Caspase-1 self-cleavage is an intrinsic mechanism to terminate inflammasome activity.

artículo científico publicado en 2018

Correction: The Cytokine Release Inhibitory Drug CRID3 Targets ASC Oligomerisation in the NLRP3 and AIM2 Inflammasomes

artículo científico publicado en 2013

Correction: The Cytokine Release Inhibitory Drug CRID3 Targets ASC Oligomerisation in the NLRP3 and AIM2 Inflammasomes

artículo científico publicado en 2013

Cytokine release inhibitor drug, CRID3, inhibits the NLRP3 inflammasome in glia

Evidence against a role for NLRP3-driven islet inflammation in db/db mice.

artículo científico publicado en 2018

GSTO1-1 modulates metabolism in macrophages activated through the LPS and TLR4 pathway.

artículo científico publicado en 2015

Glutathione transferase omega 1 is required for the lipopolysaccharide-stimulated induction of NADPH oxidase 1 and the production of reactive oxygen species in macrophages

artículo científico publicado en 2014

Interleukin-10 regulates the inflammasome-driven augmentation of inflammatory arthritis and joint destruction

artículo científico publicado en 2014

MCC950 directly targets the NLRP3 ATP-hydrolysis motif for inflammasome inhibition

scientific article published on 13 May 2019

Mitochondrial DNA synthesis fuels NLRP3 inflammasome

scientific article published on 01 November 2018

Modulatory mechanisms controlling the NLRP3 inflammasome in inflammation: recent developments

artículo científico publicado en 2013

Monounsaturated fatty acid-enriched high-fat diets impede adipose NLRP3 inflammasome-mediated IL-1β secretion and insulin resistance despite obesity.

artículo científico publicado en 2015

NLRC3 Restrains Responses to a T

artículo científico publicado en 2018

NLRP3 inflammasome priming: A riddle wrapped in a mystery inside an enigma

artículo científico publicado en 2020

New insights into the regulation of signalling by toll-like receptors and nod-like receptors.

artículo científico publicado en 2010

Questions and controversies in innate immune research: what is the physiological role of NLRP3?

artículo científico publicado en 2016

Role reversal: adaptive immunity instructs inflammasome activation for anti-viral defence

artículo científico publicado en 2019

Solution structure of the TLR adaptor MAL/TIRAP reveals an intact BB loop and supports MAL Cys91 glutathionylation for signaling.

artículo científico publicado en 2017

Sterile signals generate weaker and delayed macrophage NLRP3 inflammasome responses relative to microbial signals

artículo científico publicado en 2016

Sulfonylureas as Concomitant Insulin Secretagogues and NLRP3 Inflammasome Inhibitors.

artículo científico publicado en 2017

T helper 1 immunity requires complement-driven NLRP3 inflammasome activity in CD4⁺ T cells.

artículo científico publicado en 2016

The NLRP3 inflammasome functions as a driver of the myelodysplastic syndrome phenotype ⬇️

artículo científico publicado en 2016

The cytokine release inhibitory drug CRID3 targets ASC oligomerisation in the NLRP3 and AIM2 inflammasomes

artículo científico publicado en 2011

The intracellular chloride channel proteins CLIC1 and CLIC4 induce IL-1β transcription and activate the NLRP3 inflammasome

artículo científico publicado en 2017

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda